July 25, 2016
The Ministry of Health, Labor and Welfare (MHLW) issued a notification on July 22, alerting on the use of EGFR tyrosine kinase inhibitors (TKIs) in patients who have been treated with Opdivo (nivolumab), after three deaths caused by interstitial lung...read more